A detailed history of Core Cap Advisors, LLC transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Core Cap Advisors, LLC holds 9 shares of BMRN stock, worth $599. This represents 0.0% of its overall portfolio holdings.

Number of Shares
9
Previous 9 -0.0%
Holding current value
$599
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024

BUY
$74.43 - $92.22 $669 - $829
9 New
9 $0
Q4 2022

Feb 10, 2023

SELL
$80.93 - $108.63 $1.44 Million - $1.93 Million
-17,741 Reduced 98.93%
191 $19,000
Q3 2022

Feb 10, 2023

BUY
$82.16 - $96.94 $1.47 Million - $1.73 Million
17,847 Added 20996.47%
17,932 $1.52 Million
Q2 2022

Aug 11, 2022

BUY
$71.48 - $86.85 $6,075 - $7,382
85 New
85 $7,000
Q1 2022

Apr 29, 2022

SELL
$74.28 - $92.69 $7,428 - $9,269
-100 Closed
0 $0
Q4 2021

Feb 10, 2022

BUY
$71.72 - $91.47 $7,172 - $9,147
100 New
100 $9,000

Others Institutions Holding BMRN

About BIOMARIN PHARMACEUTICAL INC


  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $12.4B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Core Cap Advisors, LLC Portfolio

Follow Core Cap Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Core Cap Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Core Cap Advisors, LLC with notifications on news.